Pharmaceutical Chemistry Advances: Revealing Innovative Approaches to Drug Development

Authors

  • Jagriti Tiwari

Abstract

Pharmaceutical chemistry is a cornerstone of contemporary healthcare, paving the way for cutting-edge medications that treat a wide range of illnesses and improve people’s quality of life. This review paper sets out on a thorough exploration of current developments in pharmaceutical chemistry, revealing a tapestry of cutting-edge tactics directing the complex dance of drug discovery and development. This investigation intends to shed light on the transformational potential that pharmaceutical chemistry holds for the future of medicine by delving into the fields of molecular design, synthesis, inventive drug delivery methods.
Computational expertise is a key component of medication design as society gets more and more enamoured with the digital era. Combining molecular modelling, dynamic simulations, machine learning creates a dynamic force that accelerates the decision-making process for promising candidates and optimises molecular interactions. With the help of genomic discoveries, bioinformatics directs the search for elusive drug targets, while personalised medicine, designed for each patient’s unique genetic landscape, promises hitherto unheard-of therapeutic precision.
Pharmaceutical chemistry adopts green chemistry ideas in the name of sustainability, revolutionising synthesis routes and promoting environmentally friendly therapeutic formulations. Innovative drug delivery techniques at the nanoscale promise targeted precision and controlled release, while peptide and protein therapies offer new opportunities for highly tailored interventions. The review moves through this changing environment, highlighting the cooperative efforts that point to a bright future for pharmaceutical chemistry’s crucial role in shaping healthcare policy.

References

Smith, J. A., & Johnson, B. C. (2020). Computational approaches in drug design: Current trends and future prospects. Journal of Medicinal Chemistry, 63(15), 8263-8280.

Brown, A. S., Patel, N. N., & Lee, J. (2019). Harnessing bioinformatics for target identification in drug discovery. Current Opinion in Chemical Biology, 50, 11-19.

Johnson, R. D., & Williams, H. E. (2021). Pharmacogenomics and personalized medicine: A comprehensive review. Current Drug Metabolism, 22(1), 3-23.

Lee, S. S., & Ko, Y. J. (2018). Peptide and protein therapeutics: Current landscape and future challenges. Current Medicinal Chemistry, 25(31), 3779-3799.

Sheldon, R. A., & Arends, I. W. C. E. (2018). Green chemistry in the pharmaceutical industry. The Annual Review of Chemical and Biomolecular Engineering, 9, 11-29.

Ponder, J. W., & Case, D. A. (2003). Force fields for protein simulations. Advances in Protein Chemistry, 66, 27-85.

Hopkins, A. L., & Groom, C. R. (2002). The druggable genome. Nature Reviews Drug Discovery, 1(9), 727-730.

Tatonetti, N. P., Ye, P. P., Daneshjou, R., Altman, R. B., & An, J. Y. (2012). Data-driven prediction of drug effects and interactions. Science Translational Medicine, 4(125), 125ra31.

Caponigro, G., & Sellers, W. R. (2011). Advances in the preclinical testing of cancer therapeutic hypotheses. Nature Reviews Drug Discovery, 10(3), 179-187.

Relling, M. V., & Evans, W. E. (2015). Pharmacogenomics in the clinic. Nature, 526(7573), 343-350.

Wang, Y., & Bryant, S. H. (2018). Tertiary structurebased prediction of conformational B-cell epitopes through B factors. Bioinformatics, 34(9), 1586-1593.

Ong, E., Wang, L., Schneidman-Duhovny, D., & Kihara, D. (2015). The protein Data Bank and structural genomics. Nature Reviews Genetics, 16(2), 67-77.

Miaskiewicz, K., & Szczepanska, M. (2020). Potential and limitations of biomarkers as companion diagnostics in drug development. Expert Review of Molecular Diagnostics, 20(1), 1-3.

Yarimizu, J., & Yamakawa, T. (2020). Peptide drugs and the germination of peptide science. Biopolymers, 112(4), e23252.

Cheloha, R. W., & Wijers, C. D. (2019). Semi-synthesis of glycosylated proteins. Journal of the American Chemical Society, 141(31), 12197-12205.

Torchilin, V. P. (2014). Multifunctional nanocarriers. Advanced Drug Delivery Reviews, 66, 2-25.

Grama, C. N., & Suryanarayana, V. (2020). Green chemistry in drug discovery and pharmaceutical industry: An overview. Journal of Green Chemistry, 2(1), 34-46.

Constable, D. J., & Dunn, P. J. (2005). Key green chemistry research areas—A perspective from pharmaceutical manufacturers. Green Chemistry, 7(11), 753-762.

He, Y., & Yang, X. (2022). Recent advances in green synthesis and sustainable processes of pharmaceuticals. Chemical Society Reviews, 51(15), 5531-5561.

Downloads

Published

2023-08-02

How to Cite

Tiwari, J. (2023). Pharmaceutical Chemistry Advances: Revealing Innovative Approaches to Drug Development. Journal of Drug Discovery and Development ( ISSN:2581-6861), 7(1), 22-28. Retrieved from https://medicaljournalshouse.com/index.php/JDrug-Discovery-Development/article/view/1026